South Korean biotech company PnP Biopharm is making strides in the cosmeceutical industry with its cutting-edge technology. Leveraging expertise in stem cells and exosome development, the company has launched its skincare brand exosome brand labossen, introducing innovative solutions for skin and scalp health.

Founded in 2011, PnP Biopharm specializes in protein engineering and holds proprietary technologies, including PnP-Growth Factor, high-efficiency protein production technology Vexpress®, and stabilization platform Vexteel®. Traditional growth factor protein ingredients require storage in powder form to maintain activity and must be used within two weeks after dissolving. However, PnP Biopharm has developed stabilized growth factor ingredients that can be stored in liquid form at room temperature for over a year, and in freeze-dried powder form for three to five years while maintaining full activity. This technological advancement sets the company apart from competitors and enables broad applications in both pharmaceuticals and functional cosmetics.

Building on this expertise, PnP Biopharm has launched exosome brand labossen as part of its expansion into the cosmeceutical market. The brand’s flagship products include Labossen Bio-Xome Skin, Labossen Bio-Xome Hair, Labossen Pink EX Booster, Labossen Prof. AC Complex, and Labossen Lipo Silhouette. Exosome brand labossen's Hyper Exosome Technology has been recognized for overcoming the limitations of conventional exosome products. Developed through over 30 years of biotechnology research, it addresses issues related to ingredient degradation due to body temperature sensitivity.

Exosome development technology has been gaining traction in both skincare and medical applications. Exosomes are nano-sized extracellular vesicles (EVs) encased in a lipid bilayer, containing proteins, lipids, nucleic acids, and metabolic substances. Research into EV-based therapeutics and diagnostics is rapidly advancing, particularly in the field of stem cells. Interest in stem cell-derived exosome development has surged due to its regenerative and anti-inflammatory effects. PnP Biopharm, in collaboration with Konkuk University’s KU Convergence Science and Technology Institute, has confirmed that its PnP-Growth Factor demonstrates superior efficacy in exosome development using stem cells.

With exosome development being recognized for its effectiveness in skin regeneration, anti-aging, and inflammation reduction, its applications in skincare and medical technology continue to expand. A representative from exosome brand labossen stated, “Labossen is setting a new standard in skincare with its Hyper Exosome Technology, leading the industry with next-generation skincare solutions. We will continue to advance our research and development to deliver even better skincare innovations.”